Japan Hospital Cancer Diagnostics Market, 2019-2023: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review

This new report contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including: 

  • Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. 
  • Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. 
  • Test volume and sales forecasts for 40 cancer diagnostic procedures performed in Japanese hospitals. 
  • Current instrumentation technologies and feature comparison of leading analyzers. 
  • Sales and market shares of  leading suppliers. 
  • Emerging diagnostic technologies and their potential market applications. 
  • Product development opportunities. 
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 
  • Business opportunities and strategic recommendations for supplier



    Introduction
    Worldwide Market and Technology Overview
    A. Cancer Statistics and Etiology
    1. Breast Cancer
    2. Lung Cancer
    3. Colon and Rectum Cancer
    4. Prostate Cancer
    5. Stomach Cancer
    6. Leukemia
    7. Lymphoma
    8. Oral Cancer
    9. Skin Cancer
    10. Uterine Cancer
    11. Ovarian Cancer
    12. Bladder Cancer
    B. Major Current And Emerging Cancer Diagnostic Tests
    1. Introduction
    2. Tumor Marker Classification
    3. ACTH
    4. Alpha-Fetoprotein (AFP)
    5. Beta-2 Microglobulin
    6. CA 15-3/27.29
    7. CA 19-9
    8. CA-125
    9. Calcitonin
    10. Carcinoembrionic Antigen (CEA)
    11. Estrogen and Progesterone Receptors
    12. Ferritin
    13. Gastrin
    14. Human Chorionic Gonadotropin (HCG)
    15. Insulin

    16. NSE
    17. Occult Blood
    18. PAP Smear/HPV
    19. Prostatic Acid Phosphatase (PAP)
    20. Prostate-Specific Antigen (PSA)
    21. Squamous Cell Carcinoma Antigen (SCC)
    22. T and B Lymphocytes
    23. TdT
    24. Thyroglobulin
    25. Tissue Polypeptide Antigen (TPA)
    26. Biochemical Tumor Markers
    - ADA
    - B-Protein
    - PNP
    - 5-Nucleotidase
    27. Oncogenes
    - Abl/abl-bcr
    - AIB1
    - BCL-2
    - BRCA1
    - CD44
    - C-fos
    - C-myb
    - C-myc
    - CYP-17
    - Erb-B
    - HPC1
    - N-myc
    - P40
    - P51
    - P53
    - PIK3CA
    - PTI-1
    - Ras
    - Reg
    - Sis
    - Src


    28. Polypeptide Growth Factors
    - Basic Fibroblast Growth Factor
    - Beta-TGF
    - Cachectin (TNT)
    - Calmodulin
    - ECFR
    - Nerve Growth Factor (NGF)
    - Epidermal Growth Factor (EGF)
    - Ornithine Decarboxylase
    - Transferrin
    - Transforming Growth Factor-Alpha
    29. Ectopic Hormones
    30. Colony Stimulating Factors
    31. Lymphokines
    - Alpha-Interferon
    - B Cell Growth Factors
    - B Cell Growth Factor (BCGF)
    - Gamma-Interferon
    - Interleukin-1 (IL-1)
    - Macrophage Activating Factor
    32. Immunohistochemical Stains
    33. Emerging Tumor Markers
    - N-Acetylglucosamine
    - Actin
    - Alpha-Actin
    - Antineuronal Antibodies
    - 7B2
    - B72.3
    - Bax
    - BCD-F9
    - BLCA-4
    - Blood Group Antigens A,B,H
    - CA 50
    - CA 72-4/TAG-72
    - CA 195
    - CA-242
    - CA-549
    - CAM 26
    - CAR-3

    - Cathepsin-D
    - Chromogranin A and B
    - Cluster 1 Antigen
    - Cluster-5/5A Antigen
    - CTA
    - CU18
    - DR-70
    - DU-PAN-2
    - Endometrial Bleeding Associated Factor
    - Endostatin
    - Epithelial Membrane Antigen
    - Feulgen Hydrolysis
    - Fibronectin
    - FSH
    - (1->3)-L-fucosyltransferase
    - Gastrin-Releasing Peptide (GRP)
    - GDCFP-15
    - Glucagon
    - Glycoamines
    - H23
    - Her-2
    - Human Carcinoma Antigen
    - HPA
    - HSP27
    - Intermediate Filaments
    - Cytokeratins/CK18/Cyfra 21-1
    - Desmin
    - Gliofibrillary Acid Protein
    - Neurofilaments
    - Vimentin
    - KA 93
    - Kinases
    - KP16D3
    - LAI
    - Leukocyte Common Antigen
    - Lewis Antigens
    - Lysophosphatidic Acid (LPA)
    - Ma 695/Ma 552
    - MABDF3
    - MAG
    - ME1

    - Minactivin
    - MN/CA9
    - MSA
    - Mucin Cancer Antigen (MCA)
    - Multiple Tumor Suppressor 1
    - Myosin
    - NEA-130
    - NMP22
    - OA-519
    - Opiod Peptides
    - P-glycoprotein
    - Pancreatic Oncofetal Antigen (POA)
    - Placental Lactogen
    - PR92
    - Proliferative Index, Ki-67
    - Px
    - RB Inactivation/Deletion
    - Ret
    - SCCL 175
    - Selectin
    - Sialic Acid
    - Sialyl SSEA-1/SLX
    - SN10
    - Somatostatin
    - TA-90
    - TABA
    - Tachykinin
    - TAG 12
    - TPS
    - Troponin
    - Tubulin
    - VCAM
    - VEGF
    - Villen
    C. Instrumentation Review And
    Market Needs
    1. Abbott AxSYM
    2. Abbott Architect c4000
    3. Abbott Architect i2000 Series
    4. Abbott Architect ci8200 System

    5. Beckman Coulter UniCel Series
    6. Beckman Coulter Access
    7. Binding Site ESP600
    8. bioMerieux Mini Vidas
    9. Carolina Chemistries BioLis 24i
    10. DiaSorin Liaison
    11. Horiba ABX Pentra 400
    12. Inverness DS2
    13. J&J Vitros ECi/ECiQ
    14. J&J Vitros 3600
    15. J&J Vitros 5600
    16. Olympus AU5400
    17. Olympus AU3000i
    18. Olympus AU2700
    19. Roche Modular Analytics
    20. Roche Cobas Integra 400
    21. Roche Cobas Integra 400 Plus
    22. Roche Elecsys
    23. Roche Cobas c311
    24. Siemens ADVIA Centaur
    25. Siemens Dimension
    26. Siemens Dimension RxL Max
    27. Siemens Dimension Vista 500
    28. Siemens Immulite
    29. Siemens Stratus
    30. Tosoh AIA-Series
    31. Vital Diagnostics ATAC 8000
    32. Vital Diagnostics Envoy 500
    D. Current and Emerging Technologies
    1. Monoclonal and Polyclonal Antibodies
    2. Immunoassays
    a. Technological Principle
    b. Radioimmunoassay (RIA)
    c. Enzyme Immunoassays (EIA)
    - Overview
    - ELISA
    - Immunofiltration
    - Particle-Membrane Capture Immunoassay
    - Enzyme Amplification

    d. Fluorescent Immunoassays
    e. Luminescence
    - Chemiluminescence
    - Bioluminescence
    f. Latex Agglutination
    g. Immunoprecipitation
    H. Affinity Chromatographu
    e. Liposome Flow-Injection Immunoassay
    3. Molecular Diagnostics
    a. Technology Overview
    b. Amplification Methods
    - PCR
    - DAP-PCR
    - Immuno-PCR
    - QC-PCR
    - CAR
    - DNA
    - HPA
    - LCR
    - NASBA
    - QBR
    - SDA
    - 3 SR, and others
    4. Chromosome Analysis
    a. Chronic Myelogenous Leukemia (CML)
    b. Acute Myeloid Leukemia (AML)
    c. Acute Lymphoblastic Leukemia (ALL)
    d. Malignant Lymphomas
    Lymphoid Malignancies
    e. Chronic Lymphocytic Leukemia (CLL)
    f. Solid Cancers
    g. Chromosomal Translocation and Oncogenes
    5. Artificial Intelligence
    6. Flow Cytometry
    7. Two Dimensional Gel Electrophoresis (2-DGE)
    8. Biosensors
    9. Competing/Complementing Technologies
    a. CT
    b. MRI

    c. NMR
    d. PET
    e. Photonics Spectroscopy
    E. Personal Testing
    Japan
    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Growth and Major Suppliers
    Major Product Development Opportunities
    A. Reagent Kits and Test Systems/Panels
    B. Instrumentation
    C. Computers, Software and Automation
    D. Auxiliary Products
    Design Criteria for Decentralized Testing Products
    Alternative Market Penetration Strategies
    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies
    1. Marketing Approaches
    2. Product Complexity
    3. Customer Preference
    4. Established Suppliers
    5. Emerging Suppliers
    6. Major Types of Distributors
    7. Market Segmentation Factor
    Potential Market Entry Barriers and Risks
    A. Market Maturity
    B. Cost Containment
    C. Competition

    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges
    Competitive Profiles
    - Abbott
    - AdnaGen/Alere
    - Agilent Technologies
    - Applied Gene Technologies
    - Arca Biopharma
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - Biomedical Diagnostics
    - bioMerieux
    - Bio-Rad
    - CellSearch
    - Cepheid
    - Correlogic Systems/Vermillion
    - Decode Genetics
    - Diadexus
    - Diagnocure
    - Diasorin
    - Eiken Chemical
    - Elitech Group
    - Enterix
    - Enzo Biochem
    - Epigenomics
    - Exact Sciences
    - Fujirebio
    - Guided Therapeutics
    - Hologic/Gen-Probe
    - Kreatech/Leica
    - Kyowa Medex
    - Mackay Life Sciences
    - Myriad Genetics

    - OncoLab
    - Otho-Clinical Diagnostics
    - Panacea Pharmaceuticals
    - Polartechnics
    - Polymedco
    - PreMD
    - Qiagen
    - Quest Diagnostics
    - Radient Pharmaceuticals
    - Roche
    - Scienion
    - Sequenom
    - Siemens Healthcare
    - Takara Bio
    - Targeted Diagnostics & Therapeutics
    - Thermo Fisher
    - Tosoh
    - Veridex
    - Wako Pure Chemicals
    - Wallac/PE
    - Zila

    Appendixes
    Appendix I: Major Universities and Research
    Centers Developing Cancer Diagnostic
    Technology and Applications
    Appendix II: Assumed Currency Exchange Rates


    List Of Tables



    Tumor Marker Classification
    Major Companies Developing or Marketing
    ACTH Tests
    Major Companies Developing or Marketing
    AFP Tests
    Major Companies Developing or Marketing
    Beta-2 Microglobulin Tests
    Major Companies Developing or Marketing
    CA 15-3/27.29 Tests
    Major Companies Developing or Marketing
    CA 19-9 Tests
    Major Companies Developing or Marketing
    CA 125 Tests
    Major Companies Developing or Marketing
    Calcitonin Tests
    Major Companies Developing or Marketing
    CEA Tests
    Major Companies Developing or Marketing
    Estrogen Receptor Tests
    Major Companies Developing or Marketing
    Progesterone Receptor Tests
    Major Companies Developing or Marketing
    Ferritin Tests
    Major Companies Developing or Marketing
    Gastrin Tests

    Major Companies Developing or Marketing
    HCG Tests

    Major Companies Developing or Marketing
    Insulin Tests

    Major Companies Developing or Marketing
    NSE Tests
    Major Companies Developing or Marketing
    Occult Blood Tests
    Major Companies Developing or Marketing
    PAP Smear/HPV Tests
    Major Companies Developing or Marketing
    PAP Tests
    Major Companies Developing or Marketing
    PSA Tests
    Major Companies Developing or Marketing
    Lymphocyte Subclassification Tests
    Biochemical Markers Potential Applications
    In Cancer Diagnosis
    Oncogenes Potential Applications
    In Cancer Diagnosis
    Major Companies Developing or Marketing
    Oncogene Tests
    Growth Factors Potential Applications
    In Cancer Diagnosis
    Colony Stimulating Factors Potential
    Applications in Cancer Diagnosis
    Lymphokines Potential Applications
    In Cancer Diagnosis

    Immunohistochemical Stains Potential
    Applications in Cancer Diagnosis
    Executive Summary Table: Japan, Hospital
    Cancer Diagnostic Test Volume and Sales Forecast
    Japan, Estimated Cancer Death Rates
    Per 100,000 Population
    Japan, Hospital Laboratories Performing
    Cancer Diagnostic Tests
    Japan, Hospital Laboratories Performing
    Cancer Diagnostic Tests by Bed Size
    Japan, Hospital Laboratories Major
    Cancer Diagnostic Test Volume Forecast by Test
    Japan, Hospital Laboratories Cancer Diagnostic
    Sales Forecast by Test
    Japan, Total Cancer Diagnostics
    Sales by Major Supplier
    Japan, AFP Testing Market Diagnostics
    Sales by Major Supplier
    Japan, CA 15-3/27.29 Testing Market
    Diagnostics Sales by Major Supplier
    Japan, CA 19-9 Testing Market Diagnostics
    Sales by Major Supplier
    Japan, CA 125 Testing Market Diagnostics
    Sales by Major Supplier
    Japan, Calcitonin Testing Market Diagnostics
    Sales by Major Supplier

    Japan, PAP Testing Market Diagnostics
    Sales by Major Supplier
    Japan, PSA Testing Market Diagnostics
    Sales by Major Supplier

    2024 Japan Hospital Virology and Bacteriology Testing Market Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities

    This new report contains 891 pages and 75 tables.The report is available by section, and can be customized to specific information needs and budget.The report presents a comprehensive analysis of

    USD 3500 View Report

    2024 Japan Hepatitis Diagnostic Testing for 10 Markers Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations

    The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.The report is available by section,

    USD 2500 View Report

    2024 Japan Hospital Virology and Bacteriology Testing Market Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities

    This new report contains 891 pages and 75 tables.The report is available by section, and can be customized to specific information needs and budget.The report presents a comprehensive analysis of

    USD 3500 View Report

    2020 Japan Hospital Hemostasis Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Forecasts, Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

    This new report contains 392 pages, 28 tables, and presents a comprehensive analysis of the Japanese hospital hemostasis diagnostic testing market, including: Major issues pertaining to the Japanese coagulation laboratory practice,

    USD 3500 View Report

    Fill The Form For Sample Request

    Note : * Kindly provide us with your company id and get the sample reports at the earliest.

    There is no Reviews available